These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8181253)

  • 1. Fructosamine in obese normal subjects and type 2 diabetes.
    Ardawi MS; Nasrat HA; Bahnassy AA
    Diabet Med; 1994; 11(1):50-6. PubMed ID: 8181253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of obesity on plasma fructosamine concentration.
    Woo J; Cockram C; Lau E; Chan A; Swaminathan R
    Clin Chem; 1992 Nov; 38(11):2190-2. PubMed ID: 1424109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the fructosamine test in obesity: consequences for the assessment of past glycemic control in diabetes.
    Broussolle C; Tricot F; Garcia I; Orgiazzi J; Revol A
    Clin Biochem; 1991 Apr; 24(2):203-9. PubMed ID: 2040093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.
    De Michele G; Correale M; De Michele O; Guerra V; Mazzarelli R; Misciagna G
    Immunopharmacol Immunotoxicol; 2008; 30(4):925-36. PubMed ID: 18720163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of glycosylated plasma protein determination in the diagnosis of carbohydrate intolerance in obesity].
    Ardizzi A; Grugni G; Moreni G; Sartorio A; Conti A; Morabito F
    Minerva Med; 1990 Nov; 81(11):773-6. PubMed ID: 2255412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated serum protein determination: comparison between thiobarbituric acid and fructosamine assays.
    Poli T; Lapolla A; Plebani M; Franchin A; Fedele D
    Acta Diabetol Lat; 1987; 24(3):241-7. PubMed ID: 3687316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated haemoglobin and glycated plasma protein, a comparative study.
    Ross IS; Mitchell AF; Stroud RE
    Clin Chim Acta; 1986 May; 156(3):329-35. PubMed ID: 3719989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of the determination of fructosamine in monitoring diabetic patients].
    Vinci VS; Masotti G; Citro G; De Marca S; Quaglia C; Galasso R
    Medicina (Firenze); 1990; 10(1):25-7. PubMed ID: 2381275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects.
    Diabet Med; 1994 Jul; 11(6):534-44. PubMed ID: 7955969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial measurement of serum fructosamine and glycosylated haemoglobin as indices of glycaemic control in diabetic pregnancy.
    Thai AC; Lui KF; Low EG; Ng WY; Kek LP
    Ann Acad Med Singap; 1991 Nov; 20(6):732-5. PubMed ID: 1803958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical performance evaluation of BM/Hitachi 747-200 serum fructosamine assay.
    Lin MJ; Hoke C; Ettinger B; Coyne RV
    Clin Chem; 1996 Feb; 42(2):244-8. PubMed ID: 8595718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects.
    Negoro H; Morley JE; Rosenthal MJ
    Am J Med; 1988 Sep; 85(3):360-4. PubMed ID: 3414731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fructosamine in patients with diabetes mellitus.
    Baker J; Reid I; Holdaway I
    N Z Med J; 1985 Jul; 98(782):532-5. PubMed ID: 3861965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.
    Baker JR; O'Connor JP; Metcalf PA; Lawson MR; Johnson RN
    Br Med J (Clin Res Ed); 1983 Sep; 287(6396):863-7. PubMed ID: 6412861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fructosamine in the assessment of glycaemic control in diabetes mellitus.
    Koskinen P; Irjala K; Viikari J; Panula-Ontto R; Matikainen MT
    Scand J Clin Lab Invest; 1987 May; 47(3):285-92. PubMed ID: 3589493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obese patients with type 2 diabetes poorly controlled by insulin and metformin: effects of adjunctive dexfenfluramine therapy on glycaemic control.
    Willey KA; Molyneaux LM; Yue DK
    Diabet Med; 1994; 11(7):701-4. PubMed ID: 7955998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.